Hematology/Oncology News

CMS has released its proposed 2025 Medicare Physician Fee Schedule, or PFS, which includes a 2.93% cut in physician payments from the previous year, according to a press release.

Compared with non-Hispanic white individuals, patients from racial and ethnic minority groups experienced similar clinical benefits when participating in phase 1 trials for advanced cancers, data published in JAMA Network Open showed.

U.S. women medical school deans reported expectations of being more proactive, participating in external leadership development programs and confronting biases during the search process vs. their male counterparts, according to a study.

About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.

The posts on X (formerly Twitter) looked like advertisements to Aaron P. Mitchell, MD, MPH.

An AI model achieved higher accuracy than three cytopathologists for determining malignancy in a large dataset of image patches of thyroid fine-needle aspiration whole-slide images, according to a study published in Thyroid.

In this episode, host Shikha Jain, MD, speaks with Komal Jhaveri, MD, about breakthroughs in breast cancer treatment, where the field is evolving with anti-body drug conjugates and more.

Although adherence to standardized reporting guidelines ranged from 82.4% to 92.2% in published trials of colorectal cancer screening, researchers found that reporting of trial registration and informed consent materials could be improved.

Underweight childhood cancer survivors are at an increased risk for late mortality, according to data from a retrospective cohort study published in Pediatric Blood & Cancer.

A continuous risk score accurately predicted waitlist dropout and post-liver transplantation outcomes in patients with hepatocellular carcinoma, even over the course of several UNOS policy changes, researchers reported.